In a world in dire need of more vaccines to fight COVID-19, some media houses are stirring up controversy over Chinese vaccines – again! Some accuse China of profiting from the recent deal between the World Health Organization-backed COVAX and Chinese vaccine manufacturers Sinopharm and Sinovac, which will provide up to 550 million doses to lower-income countries. Others are still planting seeds of doubt over the efficacy of Chinese vaccines even though they have been proven effective in trials and approved by the WHO for emergency use. Is this really the kind of coverage the world needs right now as the aggressive Delta variant spreads, cases continue to rise in many parts of the world and vaccine inequity remains a crucial problem to tackle? Don't miss Headline Buster to find out more!